lurasidone-hydrochloride and Diabetic-Ketoacidosis

lurasidone-hydrochloride has been researched along with Diabetic-Ketoacidosis* in 1 studies

Other Studies

1 other study(ies) available for lurasidone-hydrochloride and Diabetic-Ketoacidosis

ArticleYear
Lurasidone-induced hyperosmolar hyperglycemic syndrome: A case report.
    Neuropsychopharmacology reports, 2022, Volume: 42, Issue:3

    Lurasidone has few metabolic adverse effects and is recommended as an alternative when other antipsychotic drugs considerably increase body weight or blood sugar concentrations.. An 81-year-old man with bipolar disorder developed hyperosmolar hyperglycemic syndrome as a side effect of lurasidone. Routine monitoring of blood glucose concentrations led to the early detection and treatment of this disease, preventing life-threatening complications.. We describe a rare case of lurasidone-induced hyperosmolar hyperglycemic syndrome. The mortality rate of this syndrome is estimated to be up to 20%. This rate is significantly higher than that of diabetic ketoacidosis (currently <2%). Although lurasidone is considered to have a low risk of raising blood glucose concentrations, symptoms of hyperglycemia must be evaluated and blood glucose concentrations should be monitored regularly.

    Topics: Aged, 80 and over; Antipsychotic Agents; Blood Glucose; Diabetic Ketoacidosis; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Lurasidone Hydrochloride; Male

2022
chemdatabank.com